Provided by Tiger Trade Technology Pte. Ltd.

GRI BIO INC

0.4193
-0.0593-12.39%
Post-market: 0.4190-0.0003-0.07%17:36 EST
Volume:1.20M
Turnover:519.70K
Market Cap:2.46M
PE:-0.03
High:0.4720
Open:0.4695
Low:0.3950
Close:0.4786
52wk High:15.64
52wk Low:0.3950
Shares:5.87M
Float Shares:5.87M
Volume Ratio:0.29
T/O Rate:20.43%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-13.9488
EPS(LYR):-55.2058
ROE:-397.84%
ROA:-137.52%
PB:1.24
PE(LYR):-0.01

Loading ...

Waterdrop Inc. Published 2024 ESG Report: Expanding Support to Vulnerable Groups, Providing Rural Medical Clinic Access to Over 500 Thousand Beneficiaries

prnewswire
·
Sep 25

GRI Bio Is Maintained at Buy by Ascendiant Capital

Dow Jones
·
Sep 22

U.S. RESEARCH ROUNDUP-Apple, GE Aerospace, Tesla

Reuters
·
Sep 22

GRI Bio Inc : Ascendiant Capital Markets Raises Target Price to $35 From $34

THOMSON REUTERS
·
Sep 22

Former GRI Director Lv Jianzhong: Building an ESG Ecosystem of Risk Co-governance, Value Co-creation, Standard Co-construction, Platform Co-building, and Resource Sharing

Deep News
·
Sep 19

Worthington Enterprises Releases 2025 Corporate Citizenship and Sustainability Report

GlobeNewswire
·
Sep 16

BUZZ-U.S. STOCKS ON THE MOVE-Opendoor Technologies, AIRO Group, Camurus

Reuters
·
Sep 12

BRIEF-GRI Bio Reports 6-Week Interim Lung Function Data In Ongoing Phase 2A Study In Idiopathic Pulmonary Fibrosis

Reuters
·
Sep 11

BUZZ-U.S. STOCKS ON THE MOVE -Apple, Enovix, Kroger

Reuters
·
Sep 11

GRI Bio Shares up 123% Premarket After Co Reports Mid-Stage Trial Data for Lung Disease Drug

THOMSON REUTERS
·
Sep 11

BUZZ-GRI Bio climbs on lung disease drug trial data

Reuters
·
Sep 11

GRI Bio Inc - GRI-0621 Shows No Worsening of Fvc at 6 Weeks

THOMSON REUTERS
·
Sep 11

GRI Bio Reports 6-Week Interim Lung Function Data in Ongoing Phase 2a Study in Idiopathic Pulmonary Fibrosis (“Ipf”)

THOMSON REUTERS
·
Sep 11

GRI Bio Inc - No Safety Concerns Observed by Idmc in GRI-0621 Study

THOMSON REUTERS
·
Sep 11

GRI Bio Inc - Phase 2a Study Fully Enrolled; Topline Data Expected Q3 2025

THOMSON REUTERS
·
Sep 11

EXL releases sixth annual Sustainability Report

GlobeNewswire
·
Sep 10

Alamos Gold Releases 2024 Annual ESG Report

GlobeNewswire
·
Aug 27

GRI Bio Q2 EPS $(1.31), Inline

Benzinga
·
Aug 14

GRI Bio to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech

GlobeNewswire
·
Aug 14

Gri Bio Inc. Conducted Virtual Annual Meeting of Stockholders

Reuters
·
Aug 14